TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35551374

Group type: EXPERIMENTAL
Intervention: Extended-Release Calcifediol (ERC) treatment (60 μg/day) for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cholecalciferol (300,000 IU/month)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extended-Release Calcifediol (ERC) treatment (30 or 60 μg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vitamin D supplements (cholecalciferol or ergocalciferol)
Number of subjects: 0
Study: 34127302

Group type: EXPERIMENTAL
Intervention: Streptokinase irrigation (150,000 IU)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Streptokinase irrigation (50,000 IU)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Saline irrigation
Number of subjects: 108
Study: 32303700

Group type: EXPERIMENTAL
Intervention: Biologic agents with different modes of action
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aminosalicylate therapy
Number of subjects: 0
Study: 35845502

Group type: EXPERIMENTAL
Intervention: Self-administered acupressure (SAA) combined with usual care
Number of subjects: 114

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 114
Study: 33292667

Group type: EXPERIMENTAL
Intervention: CREST intervention (7-week cognitive stimulation programme followed by an 8-week physical exercise programme for people with dementia and a 6-week educational programme for caregivers)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CREST intervention
Number of subjects: 10
Study: 35133113

Group type: EXPERIMENTAL
Intervention: Bimekizumab self-injection using safety syringe
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Bimekizumab self-injection using auto-injector
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Bimekizumab self-injection at Baseline (both devices)
Number of subjects: 211
Study: 34579796

Group type: EXPERIMENTAL
Intervention: Active rTMS before ECT
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sham rTMS before ECT
Number of subjects: 56
Study: 33563233

Group type: EXPERIMENTAL
Intervention: MRI-based radiomics predictive model
Number of subjects: 132
Study: 32470635

Group type: EXPERIMENTAL
Intervention: Shockwave coronary IVL catheter
Number of subjects: 0
Study: 35343723

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Trauma Recovery for Refugees (MBTR-R)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 158
Study: 34273680

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD; n = 10)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: High-protein diet (HP; n = 10)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: High-protein diet with whey supplementation (HPW; n = 10)
Number of subjects: 33
Study: 35593915

Group type: EXPERIMENTAL
Intervention: Oral delta‐9‐tetrahydrocannabinol (THC) 7.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral delta‐9‐tetrahydrocannabinol (THC) 15 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: THC (7.5 mg and 15 mg)
Number of subjects: 0
Study: 34766228

Group type: EXPERIMENTAL
Intervention: Stachys schtschegleevii tea (2.4 g/day SSC + 2.4 g/day black tea)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (2.4 g/day black tea)
Number of subjects: 44
Study: 34115106

Group type: EXPERIMENTAL
Intervention: COVID-19 patients
Number of subjects: 54
Study: 36308367

Group type: EXPERIMENTAL
Intervention: FOLFOXIRI
Number of subjects: 64

Group type: COMPARATOR
Intervention: FOLFIRI or FOLFOX4
Number of subjects: 64
Study: 33606266

Group type: EXPERIMENTAL
Intervention: High-throughput RNA-sequencing experiments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Factors affecting RNA-sequencing experiments
Number of subjects: 0
Study: 32639698

Group type: EXPERIMENTAL
Intervention: PEEK RPDs
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Cobalt-Chromium (Co-Cr) RPDs
Number of subjects: 26

Group type: COMPARATOR
Intervention: Participant preference
Number of subjects: 26

Group type: COMPARATOR
Intervention: Gingival Bleeding Index (GBI)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Plaque Index (PI)
Number of subjects: 26

Group type: COMPARATOR
Intervention: McGill Denture Satisfaction Questionnaire (MDSQ)
Number of subjects: 26
Study: 35023026

Group type: EXPERIMENTAL
Intervention: Supportive care and anticoagulation therapy
Number of subjects: 172
Study: 33445686

Group type: EXPERIMENTAL
Intervention: Home-based stair climbing
Number of subjects: 50
Study: 35859246

Group type: EXPERIMENTAL
Intervention: Summary statement prompt
Number of subjects: 114

Group type: COMPARATOR
Intervention: Non-prompted control group
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Summary statement scoring (0, 0.5, 1)
Number of subjects: 114
Study: 33729391

Group type: EXPERIMENTAL
Intervention: Exercise Training (ET) - 3 weekly sessions of aerobic exercise, local strengthening, and stretching exercises (72 sessions over 40±3.9 weeks)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Untrained group
Number of subjects: 44
Study: 36049573

Group type: EXPERIMENTAL
Intervention: BD ChloraPrep™ (2% w/v chlorhexidine gluconate + 70% v/v isopropyl alcohol)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: BD PurPrep™ (8.3% w/w povidone‐iodine + 72.5% w/w isopropyl alcohol)
Number of subjects: 103
Study: 33359356

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 36096746

Group type: EXPERIMENTAL
Intervention: Combination of 3D virtual reality and hands-on horticultural activities (8-week intervention)
Number of subjects: 62
Study: 32033745

Group type: EXPERIMENTAL
Intervention: Gadoxetic acid-enhanced MRI
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Classification tree analysis (CTA)
Number of subjects: 221
Study: 33098883

Group type: EXPERIMENTAL
Intervention: Machine learning algorithm (recurrent neural network) for predicting endoscopic Mayo score (eMS)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Machine learning algorithm (recurrent neural network) for predicting Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
Number of subjects: 249
Study: 32147036

Group type: COMPARATOR
Intervention: Heat plus vacuum device
Number of subjects: 30

Group type: COMPARATOR
Intervention: Heat only device
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sham device
Number of subjects: 30
Study: 36203158

Group type: EXPERIMENTAL
Intervention: Right tracheal displacement (RTD) maneuver
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (standard intubation technique)
Number of subjects: 108
Study: 33458763

Group type: EXPERIMENTAL
Intervention: Omadacycline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Linezolid
Number of subjects: 0
Study: 32056311

Group type: EXPERIMENTAL
Intervention: Naltrexone, acamprosate, or placebo with combined behavioral intervention or medication management in COMBINE
Number of subjects: 2125

Group type: EXPERIMENTAL
Intervention: Social behavior network therapy or motivational enhancement therapy in UKATT
Number of subjects: 2125
Study: 35410334

Group type: EXPERIMENTAL
Intervention: PD-(L)1 blockade in patients with brain and adrenal gland metastases
Number of subjects: 2062

Group type: EXPERIMENTAL
Intervention: PD-(L)1 blockade in PD-L1-positive populations (PD-L1 > 1%)
Number of subjects: 2062

Group type: EXPERIMENTAL
Intervention: METscore in patients receiving PD-(L)1 blockade
Number of subjects: 2062

Group type: EXPERIMENTAL
Intervention: METscore in FIR trial
Number of subjects: 2062

Group type: EXPERIMENTAL
Intervention: METscore in BIRCH trial
Number of subjects: 2062

Group type: EXPERIMENTAL
Intervention: METscore in real-world NFyy cohort
Number of subjects: 2062

Group type: EXPERIMENTAL
Intervention: PD-(L)1 blockade as first-line treatment in clinical trials
Number of subjects: 2062

Group type: EXPERIMENTAL
Intervention: PD-(L)1 blockade as first-line treatment in real-world practice
Number of subjects: 2062

Group type: COMPARATOR
Intervention: Chemotherapy in patients with various metastatic sites
Number of subjects: 2062
Study: 32607570

Group type: EXPERIMENTAL
Intervention: Obstacles related to family behaviors
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Obstacles related to nurse issues
Number of subjects: 509

Group type: COMPARATOR
Intervention: Obstacles related to unit design and visiting hours
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Helpful behaviors
Number of subjects: 509
Study: 32417770

Group type: EXPERIMENTAL
Intervention: CN-105
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study: 35048316

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 126
Study: 33399382

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 51

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 51
Study: 36302890

Group type: EXPERIMENTAL
Intervention: Molecular testing and targeted therapy (specific details not provided)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Not applicable (non-randomized patients)
Number of subjects: 317
Study: 33803951

Group type: EXPERIMENTAL
Intervention: Ginger root powder (0.5 g/kg)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Ginger root powder (1 g/kg)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Ginger root powder (1.5 g/kg)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Ginger root powder (0.5, 1, and 1.5 g/kg)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Basal diet (control)
Number of subjects: 240
Study: 35354410

Group type: EXPERIMENTAL
Intervention: baricitinib 2 mg
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: baricitinib 1 mg
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: baricitinib 1 mg and 2 mg
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: baricitinib (1 mg and 2 mg)
Number of subjects: 440
Study: 33947642

Group type: EXPERIMENTAL
Intervention: Intradialytic resistance training (12-week supervised, progressive)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (inactive during dialysis)
Number of subjects: 90
Study: 32429619

Group type: EXPERIMENTAL
Intervention: Mail survey with $1 prepaid incentive
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mail survey with $10 promised incentive
Number of subjects: 0

Group type: COMPARATOR
Intervention: In-person survey
Number of subjects: 0
Study: 32598735

Group type: EXPERIMENTAL
Intervention: R-HD-MTX-AraC
Number of subjects: 47

Group type: COMPARATOR
Intervention: R-GIDIOX
Number of subjects: 47
Study: 35595197

Group type: EXPERIMENTAL
Intervention: Increased FSH dosing (300 IU/day for AFC 1-6, 225 IU/day for AFC 7-9)
Number of subjects: 661

Group type: COMPARATOR
Intervention: Standard FSH dosing (150 IU/day)
Number of subjects: 661

Group type: EXPERIMENTAL
Intervention: Increased FSH dosing
Number of subjects: 661

Group type: COMPARATOR
Intervention: Standard FSH dosing
Number of subjects: 661
Study: 36068618

Group type: EXPERIMENTAL
Intervention: Intensive family‐based lifestyle modification programme
Number of subjects: 3682

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3682
Study: 32680465

Group type: EXPERIMENTAL
Intervention: Multidisciplinary team intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 34005830

Group type: EXPERIMENTAL
Intervention: Modified glycoprotein plant extract (blocker) added to polysensitised samples
Number of subjects: 4614
Study: 33528659

Group type: EXPERIMENTAL
Intervention: 12-session Nonviolent Resistance Parent Training (NVR)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Waiting list (Control)
Number of subjects: 101
Study: 36050448

Group type: EXPERIMENTAL
Intervention: Trastuzumab (T)
Number of subjects: 2821

Group type: EXPERIMENTAL
Intervention: Trastuzumab (T) + Lapatinib (L)
Number of subjects: 2821

Group type: COMPARATOR
Intervention: Lapatinib (L)
Number of subjects: 2821

Group type: EXPERIMENTAL
Intervention: Trastuzumab (T) + chemotherapy
Number of subjects: 2821
Study: 36290905

Group type: EXPERIMENTAL
Intervention: Non-HBV cirrhosis patients with PSQI > 5
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Non-HBV cirrhosis patients
Number of subjects: 202

Group type: COMPARATOR
Intervention: HBV cirrhosis patients
Number of subjects: 202
Study: 33471788

Group type: EXPERIMENTAL
Intervention: DUDA (anti-stenosis device)
Number of subjects: 265

Group type: COMPARATOR
Intervention: No DUDA (control group)
Number of subjects: 265
Study: 32161453

Group type: EXPERIMENTAL
Intervention: High-dose group 1 (H1, 8 mg/day, 2 mg Q6h)
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: High-dose group 2 (H2, 8 mg/day, 4 mg Q12h)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Low dose group (L, 4 mg/day, 1 mg Q6h)
Number of subjects: 321
Study: 35883231

Group type: EXPERIMENTAL
Intervention: Meal, Ready-to-EatTM military ration diet (MRE) for 21 days
Number of subjects: 54

Group type: COMPARATOR
Intervention: Usual diet (CON)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: MRE diet
Number of subjects: 54
Study: 33562452

Group type: EXPERIMENTAL
Intervention: Scaling and root planing + melatonin
Number of subjects: 54

Group type: COMPARATOR
Intervention: Scaling and root planing + placebo
Number of subjects: 54
Study: 34793687

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS) - mometasone, 200 μg or 220 μg twice daily
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Long-acting muscarinic antagonists (LAMA) - tiotropium, 5 μg daily
Number of subjects: 295

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 295
Study: 34535755

Group type: EXPERIMENTAL
Intervention: Digital Diabetes Intervention (monthly messages through an online health platform)
Number of subjects: 10429

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 10429

Group type: EXPERIMENTAL
Intervention: Completion of one or more intervention messages
Number of subjects: 10429
Study: 35525389

Group type: EXPERIMENTAL
Intervention: High-frequency oscillations (HFO) evoked by electrical nerve stimulation at around 650 Hz in contralateral S1
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Short interval intracortical facilitation (SICF) measured with paired-pulse TMS
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cortical myelin content measured using T1- and T2-weighted MRI signal ratio
Number of subjects: 24
Study: 34348260

Group type: EXPERIMENTAL
Intervention: Tolvaptan (early group)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Tolvaptan (late group)
Number of subjects: 201
Study: 35953808

Group type: EXPERIMENTAL
Intervention: Switching antipsychotic medication
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Qualitative interviews with front‐line clinicians
Number of subjects: 10
Study: 32543421

Group type: EXPERIMENTAL
Intervention: Moving to Opportunity (MTO) housing voucher experiment
Number of subjects: 0
Study: 35868244

Group type: EXPERIMENTAL
Intervention: 1-hour sound therapy
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 3-hour sound therapy
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 5-hour sound therapy
Number of subjects: 58
Study: 33964166

Group type: EXPERIMENTAL
Intervention: dCBT‐I
Number of subjects: 1720

Group type: COMPARATOR
Intervention: Patient education about sleep
Number of subjects: 1720
Study: 32723728

Group type: EXPERIMENTAL
Intervention: Teens Taking Charge self-management intervention
Number of subjects: 333

Group type: COMPARATOR
Intervention: Education control group
Number of subjects: 333
Study: 36341025

Group type: EXPERIMENTAL
Intervention: Conjugated oestrogens plus bazedoxifene, orally once every day for 24 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo, orally once every day for 24 weeks
Number of subjects: 28
Study: 32430142

Group type: EXPERIMENTAL
Intervention: Calcipotriol/betamethasone dipropionate (Cal/BD) foam
Number of subjects: 649

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 649
Study: 34275783

Group type: EXPERIMENTAL
Intervention: Combined treatment with hydralazine and sodium nitroprusside
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group with sodium nitroprusside
Number of subjects: 126
Study: 33028415

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (EG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 0
Study: 35041634

Group type: EXPERIMENTAL
Intervention: Norfloxacin 400 mg once daily for 30 days
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study: 32979860

Group type: EXPERIMENTAL
Intervention: Fusidic acid cream
Number of subjects: 60

Group type: COMPARATOR
Intervention: Erythromycin ointment
Number of subjects: 60
Study: 34326841

Group type: EXPERIMENTAL
Intervention: Low Dose Naltrexone (LDN, 3.0–5.0 mg/day)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Pregnenolone sulfate (PregS)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Ononetin (TRPM3-antagonist)
Number of subjects: 9
Study: 36103244

Group type: EXPERIMENTAL
Intervention: Face-to-face and WhatsApp-based health education intervention (SeBF module)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Usual routine care (control group)
Number of subjects: 172
Study: 33509720

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 16
Study: 36476322

Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 363

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 363

Group type: COMPARATOR
Intervention: Etomidate
Number of subjects: 363
Study: 32492131

Group type: EXPERIMENTAL
Intervention: 2-stage Turnbull-Cutait pull-through hand-sewn coloanal anastomosis
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard hand-sewn coloanal anastomosis with diverting ileostomy
Number of subjects: 92
Study: 36474100

Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (bLF) 600 mg daily for 90 days
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (bLF)
Number of subjects: 209
Study: 33630642

Group type: EXPERIMENTAL
Intervention: Supportive behavior from partner
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Negative control behavior from partner
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Days with more supportive behavior than usual
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Discrepancy in support perception (more support reported by smoker than provided by partner)
Number of subjects: 170
Study: 32220028

Group type: EXPERIMENTAL
Intervention: Ayahuasca
Number of subjects: 0
Study: 35873384

Group type: EXPERIMENTAL
Intervention: Hydrogen-rich saline (HRS) irrigation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline (NS) irrigation
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Hydrogen-rich saline (HRS) irrigation in AR subgroup
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline (NS) irrigation in AR subgroup
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Hydrogen-rich saline (HRS) irrigation in NAR subgroup
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline (NS) irrigation in NAR subgroup
Number of subjects: 120
Study: 34803424

Group type: EXPERIMENTAL
Intervention: Rg3-enriched Korean Red Ginseng (Rg3-KRG) + American Ginseng (AG) at 2.25 g/day
Number of subjects: 80

Group type: COMPARATOR
Intervention: Wheat-bran control
Number of subjects: 80
Study: 35523395

Group type: EXPERIMENTAL
Intervention: Chaiqin Qingning Capsule (CQQNC)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Qingkailing Capsule (QKLC)
Number of subjects: 269
Study: 33907786

Group type: EXPERIMENTAL
Intervention: 0 g of far-distal orthodontic force
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 50 g of far-distal orthodontic force
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 150 g of far-distal orthodontic force
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 250 g of far-distal orthodontic force
Number of subjects: 96
Study: 35143012

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) prophylaxis
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Advanced age
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Pain syndrome
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Asymptomatic gallstones before surgery
Number of subjects: 959
Study: 32822287

Group type: EXPERIMENTAL
Intervention: Lapatinib (LAP) plus Trastuzumab (TRAS) plus Aromatase Inhibitor (AI)
Number of subjects: 355

Group type: COMPARATOR
Intervention: Trastuzumab (TRAS) plus Aromatase Inhibitor (AI)
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Lapatinib (LAP) plus Aromatase Inhibitor (AI)
Number of subjects: 355
Study: 34348226

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (delivered twice weekly for 8 weeks)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (usual physical education curriculum)
Number of subjects: 84
Study: 35124666

Group type: EXPERIMENTAL
Intervention: Intervention group received theory-based specific instructions to reduce smartphone-related distractions
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (CG) received no intervention
Number of subjects: 37
Study: 33492872

Group type: EXPERIMENTAL
Intervention: High flow nasal oxygen (50 l min-1 and a 50:50 oxygen to air ratio)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Facemask oxygen (≥ 8 l min-1)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: High flow nasal oxygen
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: High flow nasal oxygen and Facemask oxygen
Number of subjects: 129
Study: 32438783

Group type: EXPERIMENTAL
Intervention: LH-TL group (live high-train low protocol)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: HiHiLo group (live high - base train high - interval train low procedure)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: IHT group (intermittent hypoxic training)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (CN, normoxic training)
Number of subjects: 34
Study: 32310854

Group type: COMPARATOR
Intervention: Subcutaneous insulin therapy only
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Oral vildagliptin plus subcutaneous insulin
Number of subjects: 100
Study: 35420380

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB) applied before surgery and 1 month after surgery
Number of subjects: 162

Group type: COMPARATOR
Intervention: Non-ESPB block (control group)
Number of subjects: 162
Study: 33588077

Group type: EXPERIMENTAL
Intervention: Videoconference-delivered cognitive behaviour therapy for insomnia (CBT-I)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 124